Lymphastat C Liquid
Product Images NDC 44911-0603

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lymphastat C (NDC 44911-0603). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Energique, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lymphastat C (Enrg0578 Lymphastat C 1oz 4 13 21)

Lymphastat C (Enrg0578 Lymphastat C 1oz 4 13 21)
This is a warning and a description of a homeopathic medication called Lymphastat CYM. The warning advises that pregnant or breastfeeding women should seek health professional advice before use and to keep the medication out of reach of children. In case of overdose, medical help or Poison Control Center should be contacted. The medication should not be used if the tamper-evident seal is broken or missing and should be stored in a cool, dry place. Lymphastat CYM is said to provide temporary relief for stomach bloating, flatulence, or rhinitis. It contains active and inactive ingredients and is directed to be taken orally by adults and children five and above, three times daily or as suggested by a healthcare professional. The medication has no accepted medical evidence and is not FDA evaluated. If symptoms persist for over seven days, the user should consult a health care professional. The medication should not be used in children under twelve years of age without a doctor's consultation.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.